AVITA Medical (RCEL) Shares Outstanding (Weighted Average) (2018 - 2025)

AVITA Medical has reported Shares Outstanding (Weighted Average) for 8 years, with the latest figure at $27.9 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) rose 7.64% year-over-year to $27.9 million; the trailing twelve-month figure through Dec 2025 stood at $27.9 million (up 7.64% YoY), and the FY2025 full-year result was $27.9 million, up 7.64% from the prior year.
• Shares Outstanding (Weighted Average) for Q4 2025 stood at $27.9 million, down from $28.4 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $28.4 million in Q3 2025, with the low at $22.7 million in Q2 2021.
• Historically, Shares Outstanding (Weighted Average) has averaged $25.4 million across 5 years, with a median of $25.3 million in 2023.
• Annual changes were most pronounced in 2021 — Shares Outstanding (Weighted Average) rose 15.22% — and 2022, when it advanced 0.34%.
• AVITA Medical's Shares Outstanding (Weighted Average) stood at $24.9 million in 2021, then advanced by 0.34% to $25.0 million in 2022, then gained by 1.32% to $25.3 million in 2023, then climbed by 2.18% to $25.9 million in 2024, then advanced by 7.64% to $27.9 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $27.9 million (Q4 2025), $28.4 million (Q3 2025), and $26.4 million (Q2 2025), per Business Quant data.